InsidersTradesSigma
Discover the detailed record of transactions filed by Ellis Andrea, Director. Officer active across 1 companies, notably BridgeBio Pharma, Inc.. Cumulatively, 1 disclosures have been logged. Total volume traded: €92k. The latest transaction was filed on 15 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Andrea Ellis serves as a Board Member at BridgeBio Pharma, Inc. In this role, she contributes to overseeing the company's activities and developing its strategy. With a strong background in the pharmaceutical sector, Andrea Ellis brings valuable insights into market challenges and innovation opportunities. She is committed to ensuring that BridgeBio Pharma adheres to corporate governance standards and supports its sustainable development.